Arbutus to Present at UBS Virtual Global Healthcare Conference

Rhea-AI Summary

Arbutus Biopharma Corporation (Nasdaq: ABUS) announced that CEO William Collier will present at the UBS Virtual Global Healthcare Conference on May 19, 2020, at 11:40 AM ET. Interested parties can access the live webcast through the company's website. An archived replay will be available after the conference. Arbutus focuses on developing a cure for chronic hepatitis B virus (HBV) infection with multiple drug candidates.

News Market Reaction – ABUS

+14.58%

+14.58% Session move

In the trading session that priced this news, ABUS gained 14.58%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARMINSTER, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, today announced that William Collier, Arbutus’ President and Chief Executive Officer, will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 11:40 AM ET.

A live webcast of the presentation can be accessed through the Investors section of Arbutus' website at www.arbutusbio.com or directly at Live Webcast. An archived replay of the webcast will be available on the Company’s website after the conference.

About Arbutus

Arbutus Biopharma Corporation is a publicly traded (Nasdaq: ABUS) biopharmaceutical company dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection.  The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. For more information, visit www.arbutusbio.com.

Contact Information

Investors and Media
William H. Collier
President and CEO
Phone: 604-419-3200
Email: ir@arbutusbio.com

Pam Murphy
Investor Relations Consultant
Phone: 604-419-3200
Email: ir@arbutusbio.com

FAQ

When will Arbutus Biopharma present at the UBS Virtual Global Healthcare Conference?

Arbutus Biopharma will present at the UBS Virtual Global Healthcare Conference on May 19, 2020, at 11:40 AM ET.

Who is presenting for Arbutus Biopharma at the conference?

William Collier, President and CEO of Arbutus Biopharma, will be presenting.

How can I access the webcast for the Arbutus presentation?

The live webcast can be accessed through the Investors section on Arbutus Biopharma's website.

What is the focus of Arbutus Biopharma Corporation?

Arbutus Biopharma is dedicated to developing a cure for chronic hepatitis B virus (HBV) infection.

Will there be a replay of the Arbutus Biopharma presentation?

Yes, an archived replay of the webcast will be available on the company's website after the conference.